[HTML][HTML] Basal lamina changes in neurodegenerative disorders
Background Neurodegenerative disorders are a group of age-associated diseases
characterized by progressive degeneration of the structure and function of the CNS. Two key …
characterized by progressive degeneration of the structure and function of the CNS. Two key …
[HTML][HTML] Molecular biomarkers and their implications for the early diagnosis of selected neurodegenerative diseases
J Doroszkiewicz, M Groblewska, B Mroczko - International Journal of …, 2022 - mdpi.com
The degeneration and dysfunction of neurons are key features of neurodegenerative
diseases (NDs). Currently, one of the main challenges facing researchers and clinicians is …
diseases (NDs). Currently, one of the main challenges facing researchers and clinicians is …
Human CNS barrier-forming organoids with cerebrospinal fluid production
L Pellegrini, C Bonfio, J Chadwick, F Begum, M Skehel… - Science, 2020 - science.org
INTRODUCTION The choroid plexus is a secretory epithelial tissue of the central nervous
system (CNS) responsible for cerebrospinal fluid (CSF) production and functions as a barrier …
system (CNS) responsible for cerebrospinal fluid (CSF) production and functions as a barrier …
Longitudinal biomarkers in amyotrophic lateral sclerosis
F Huang, Y Zhu, J Hsiao‐Nakamoto… - Annals of clinical …, 2020 - Wiley Online Library
Objective To investigate neurodegenerative and inflammatory biomarkers in people with
amyotrophic lateral sclerosis (PALS), evaluate their predictive value for ALS progression …
amyotrophic lateral sclerosis (PALS), evaluate their predictive value for ALS progression …
[HTML][HTML] Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis
M Liguori, N Nuzziello, A Introna, A Consiglio… - Frontiers in molecular …, 2018 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease.
While genetics and other factors contribute to ALS pathogenesis, critical knowledge is still …
While genetics and other factors contribute to ALS pathogenesis, critical knowledge is still …
[HTML][HTML] Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
F Zahedipour, SA Hosseini, NC Henney… - Neural Regeneration …, 2022 - journals.lww.com
Inflammatory processes and proinflammatory cytokines have a key role in the cellular
processes of neurodegenerative diseases and are linked to the pathogenesis of functional …
processes of neurodegenerative diseases and are linked to the pathogenesis of functional …
Extracellular vesicles–propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases
Neurodegenerative diseases are characterised by the irreversible degeneration of neurons
in the central or peripheral nervous systems. These include amyotrophic lateral sclerosis …
in the central or peripheral nervous systems. These include amyotrophic lateral sclerosis …
[HTML][HTML] Increased interleukin-6 levels in the astrocyte-derived exosomes of sporadic amyotrophic lateral sclerosis patients
Y Chen, K Xia, L Chen, D Fan - Frontiers in Neuroscience, 2019 - frontiersin.org
Neuroinflammation plays an important role in amyotrophic lateral sclerosis (ALS)
pathogenesis. However, it is difficult to evaluate inflammation of the central nervous system …
pathogenesis. However, it is difficult to evaluate inflammation of the central nervous system …
[HTML][HTML] MicroRNAs as biomarkers in amyotrophic lateral sclerosis
C Ricci, C Marzocchi, S Battistini - Cells, 2018 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is an incurable and fatal disorder characterized by the
progressive loss of motor neurons in the cerebral cortex, brain stem, and spinal cord …
progressive loss of motor neurons in the cerebral cortex, brain stem, and spinal cord …
[HTML][HTML] Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …